收藏切换
Establishment and evaluation of in vitro galectin-3 inhibitor screening model
收藏切换
PDF
Chun-xiao MA1, Xiao-wei XING1, Shao-cong HOU1, Shu-wang HE2, Shi-qiang YAN2, Ping-ping LI1, *
Acta Pharmaceutica Sinica | 2023, 58(1) : 156 - 161
Less
收藏切换
Acta Pharmaceutica Sinica | 2023, 58(1): 156-161
Original Articles
Establishment and evaluation of in vitro galectin-3 inhibitor screening model
Full
Chun-xiao MA1, Xiao-wei XING1, Shao-cong HOU1, Shu-wang HE2, Shi-qiang YAN2, Ping-ping LI1, *
Affiliations
  • 1. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • 2. Shandong DYNE Marine Biopharmaceutical Co., Ltd., Weihai 264333, China
Published: 2023-01-12 doi: 10.16438/j.0513-4870.2022-0342
Outline
收藏切换

Galectin-3 (Gal-3) belongs to the galectin family and is specific in binding β-galactoside. Through its C-terminal domain, Gal-3 binds to the galactoside group of the glycosylated insulin receptor (IR) and inhibits IR signaling pathway, which leads to the insulin resistance. Thus, Gal-3 is a potential therapeutic target for the treatment of insulin resistance and type 2 diabetes. Here we report a simple Gal-3 screening model based on the property that Gal-3 binds to the galactoside. We expressed and purified human Gal-3 in Escherichia coli (E.coli), and labeled it with fluorescein isothiocyanate (FITC) in vitro. After incubating FITC labeled Gal-3 (Gal-3-FITC) with PANC-1 cells, which express glycosylated membrane protein, PANC-1 cells started to show green fluorescent signal due to the Gal-3-FITC binding to the glycosylated membrane protein. Gal-3 inhibitor disrupts the binding of Gal-3-FITC and PANC1 cells, subsequently leads to the decrease of the fluorescent signal in PANC-1 cells. We can evaluate the inhibitory efficiency of Gal-3 inhibitors through measurement of the fluorescent signal. Further studies show this model is simple, stable, and repeatable with a Z' factor between 0.7 and 0.85. In sum, we have successfully established an in vitro high-throughput screening model for Gal-3 inhibitors.

galectin-3  /  glycosylation  /  screening  /  chronic inflammation  /  fluorescein isothiocyanate
Chun-xiao MA, Xiao-wei XING, Shao-cong HOU, Shu-wang HE, Shi-qiang YAN, Ping-ping LI. Establishment and evaluation of in vitro galectin-3 inhibitor screening model[J]. Acta Pharmaceutica Sinica, 2023 , 58 (1) : 156 -161 . DOI: 10.16438/j.0513-4870.2022-0342
Year 2023 volume 58 Issue 1
PDF
178
65
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-0342
  • Receive Date:2022-03-21
  • Online Date:2025-11-21
  • Published:2023-01-12
Article Data
Affiliations
History
  • Received:2022-03-21
  • Revised:2022-05-19
Funding
Affiliations
    1. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
    2. Shandong DYNE Marine Biopharmaceutical Co., Ltd., Weihai 264333, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-0342
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT